APOE and Alzheimer disease: Unlike APOE-TR, nPM exposure increased the amyloid plaque loads in EFAD (APOE-TR plus five mutation in amyloidogenic genes) and J20 AD mouse models (Cacciottolo et al., 2017; Cacciottolo et al., 2020).